Ligand Pharmaceuticals (LGND) Current Ratio: History & Chart

Ligand Pharmaceuticals Incorporated(LGND)

Biotechnology · Jupiter, FL

$296.57-10.20 (-3.32%)

Delayed quote: Oct 6, 2026, 10:50 AM EDT

About Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated operates as a biopharmaceutical entity, primarily engaged in sourcing and advancing technologies to empower pharmaceutical companies globally in their efforts to discover and develop novel therapeutic solutions. Its diverse portfolio of commercialized products addresses a wide range of medical conditions. For hematologic malignancies, these include Kyprolis and Evomela, both targeting multiple myeloma, as well as Rylaze, a treatment for acute lymphoblastic leukemia and lymphoblastic lymphoma in both adult and pediatric patients. In the realm of infectious diseases, Ligand offers Veklury for moderate to severe COVID-19, Vaxneuvance for preventing invasive Streptococcus pneumoniae disease, and Pneumosil, a pneumococcal conjugate vaccine designed to protect children from pneumonia. Bone health solutions comprise Teriparatide injection for osteoporosis and Duavee for postmenopausal osteoporosis. Other key offerings include Zulresso, a Captisol-enabled formulation of brexanolone for postpartum depression; Nexterone, a Captisol-enabled amiodarone; and Noxafil-IV, a Captisol-enabled posaconazole for intravenous administration. The company’s comprehensive product lineup further extends to the Aziyo portfolio, featuring pericardial repair and CanGaroo envelope extracellular matrix products; Exemptia for autoimmune disorders; Vivitra for breast cancer; Bryxta and Zybev for a variety of indications; and Minnebro for managing hypertension. Beyond its own commercialized products, Ligand Pharmaceuticals collaborates with partners on numerous programs currently undergoing clinical development, targeting conditions such as cancer, seizure disorders, diabetes, cardiovascular ailments, muscle wasting, hepatic and renal diseases, and various other serious illnesses. The company also directly supplies Captisol materials, a proprietary technology frequently integrated into many of its drug formulations. Established in 1987, Ligand Pharmaceuticals is headquartered in Emeryville, California.

Jupiter, FL

47 employees

www.ligand.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Todd C. Davis

View full financials

LGND Current Ratio Metrics

CURRENT RATIO

31.18

CURRENT RATIO AVG TTM

20.96

CURRENT RATIO AVG 3Y

16.06

CURRENT RATIO AVG 5Y

12.15

CURRENT RATIO AVG 10Y

10.04

CURRENT RATIO AVG 15Y

7.23

CURRENT RATIO AVG 20Y

5.39

CURRENT VS TTM AVG

+48.72%

CURRENT VS 3Y AVG

+94.15%

CURRENT VS 5Y AVG

+156.56%

CURRENT VS 10Y AVG

+210.68%

CURRENT VS 15Y AVG

+331.38%

CURRENT VS 20Y AVG

+478.76%

SECTOR MEDIAN · HEALTHCARE

3.35

median of 629 covered companies

CURRENT VS SECTOR MEDIAN

+830.67%

vs the sector median at left

NAME	MARKET CAP	CURRENT RATIO	TTM	3Y	5Y
Ligand Pharmaceuticals Incorporated (LGND)	$5.94B	31.18	20.96	16.06	12.15
GRAIL Inc. (GRAL)vs ›	$5.97B	10.95	11.32	6.44	5.89
Iovance Biotherapeutics, Inc. (IOVA)vs ›	$5.80B	4.35	3.47	3.74	5.38
CG Oncology Inc. (CGON)vs ›	$5.72B	22.22	29.96	20.77	18.57
Kiniksa Pharmaceuticals International, plc (KNSA)vs ›	$5.67B	3.90	3.54	4.15	5.24
MiniMed Group, Inc. Common Stock (MMED)vs ›	$5.53B	1.81	1.62	1.66	1.66
Amneal Pharmaceuticals, Inc. (AMRX)vs ›	$6.45B	2.20	1.79	1.77	1.94
Doximity, Inc. (DOCS)vs ›	$5.38B	6.08	6.53	6.56	6.07
Lantheus Holdings, Inc. (LNTH)vs ›	$6.53B	3.06	4.11	4.19	3.61
Hims & Hers Health, Inc. (HIMS)vs ›	$6.64B	0.93	1.84	2.80	3.67

NAME

MARKET CAP

CURRENT RATIO

TTM

Ligand Pharmaceuticals Incorporated (LGND)

$5.94B

31.18

20.96

16.06

12.15

GRAIL Inc. (GRAL)vs ›

$5.97B

10.95

11.32

6.44

5.89

Iovance Biotherapeutics, Inc. (IOVA)vs ›

$5.80B

4.35

3.47

3.74

5.38

CG Oncology Inc. (CGON)vs ›

$5.72B

22.22

29.96

20.77

18.57

Kiniksa Pharmaceuticals International, plc (KNSA)vs ›

$5.67B

3.90

3.54

4.15

5.24

MiniMed Group, Inc. Common Stock (MMED)vs ›

$5.53B

1.81

1.62

1.66

Amneal Pharmaceuticals, Inc. (AMRX)vs ›

$6.45B

2.20

1.79

1.77

1.94

Doximity, Inc. (DOCS)vs ›

$5.38B

6.08

6.53

6.56

6.07

Lantheus Holdings, Inc. (LNTH)vs ›

$6.53B

3.06

4.11

4.19

3.61

Hims & Hers Health, Inc. (HIMS)vs ›

$6.64B

0.93

1.84

2.80

3.67

Current Ratio FAQ

What is the current ratio for Ligand Pharmaceuticals Incorporated (LGND)?

The current ratio for LGND stock is 31.18.

Is Ligand Pharmaceuticals Incorporated's current ratio high or low?

The current ratio of 31.18 is 157% above its 5-year average of 12.15, near the high end of its 5-year range (1.45–31.18).

What is the TTM average current ratio for Ligand Pharmaceuticals Incorporated (LGND)?

The TTM average current ratio for LGND stock is 20.96.

What is the 3Y average current ratio for Ligand Pharmaceuticals Incorporated (LGND)?

The 3Y average current ratio for LGND stock is 16.06.

What is the 5Y average current ratio for Ligand Pharmaceuticals Incorporated (LGND)?

The 5Y average current ratio for LGND stock is 12.15.

What is the 10Y average current ratio for Ligand Pharmaceuticals Incorporated (LGND)?

The 10Y average current ratio for LGND stock is 10.04.

What is the 15Y average current ratio for Ligand Pharmaceuticals Incorporated (LGND)?

The 15Y average current ratio for LGND stock is 7.23.

What is the 20Y average current ratio for Ligand Pharmaceuticals Incorporated (LGND)?

The 20Y average current ratio for LGND stock is 5.39.

DATE	CURRENT RATIO
2026-06-30	31.18
2026-03-31	21.28
2025-12-31	22.23
2025-09-30	24.69
2025-06-30	5.45
2025-03-31	5.27
2024-12-31	8.93
2024-09-30	12.49
2024-06-30	16.82
2024-03-31	20.70
2023-12-31	14.15
2023-09-30	16.15
2023-06-30	9.42
2023-03-31	3.32
2022-12-31	2.67
2022-09-30	1.63
2022-06-30	1.45
2022-03-31	6.48
2021-12-31	11.15
2021-09-30	11.90
2021-06-30	7.83
2021-03-31	4.57
2020-12-31	5.00
2020-09-30	20.28
2020-06-30	29.51
2020-03-31	40.65
2019-12-31	66.09
2019-09-30	33.14
2019-06-30	13.23
2019-03-31	8.39
2018-12-31	10.58
2018-09-30	2.20
2018-06-30	2.34
2018-03-31	1.41
2017-12-31	0.99
2017-09-30	0.97
2017-06-30	0.87
2017-03-31	0.77
2016-12-31	0.72
2016-09-30	0.62
2016-06-30	0.57
2016-03-31	10.87
2015-12-31	10.35
2015-09-30	12.94
2015-06-30	10.96
2015-03-31	10.56
2014-12-31	8.13
2014-09-30	10.77
2014-06-30	1.54
2014-03-31	1.59
2013-12-31	0.86
2013-09-30	0.51
2013-06-30	0.45
2013-03-31	0.54
2012-12-31	0.67
2012-09-30	0.58
2012-06-30	0.69
2012-03-31	0.87
2011-12-31	0.74
2011-09-30	0.63
2011-06-30	0.66
2011-03-31	0.70
2010-12-31	1.11
2010-09-30	0.96
2010-06-30	1.00
2010-03-31	1.22
2009-12-31	1.31
2009-09-30	1.13
2009-06-30	1.44
2009-03-31	1.28
2008-12-31	1.33
2008-09-30	1.66
2008-06-30	2.15
2008-03-31	2.30
2007-12-31	2.16
2007-09-30	1.94
2007-06-30	1.94
2007-03-31	1.26
2006-12-31	1.38
2006-09-30	0.28
2006-06-30	0.42
2006-03-31	0.44
2005-12-31	0.57
2005-09-30	0.52
2005-06-30	0.51
2005-03-31	0.61
2004-12-31	0.80
2004-09-30	1.75
2004-06-30	1.93
2004-03-31	2.18
2003-12-31	2.41
2003-09-30	2.29
2003-06-30	1.62
2003-03-31	1.67
2002-12-31	2.74
2002-09-30	1.75

DATE

CURRENT RATIO

2026-06-30

31.18

2026-03-31

21.28

2025-12-31

22.23

2025-09-30

24.69

2025-06-30

5.45

2025-03-31

5.27

2024-12-31

8.93

2024-09-30

12.49

2024-06-30

16.82

2024-03-31

20.70

2023-12-31

14.15

2023-09-30

16.15

2023-06-30

9.42

2023-03-31

3.32

2022-12-31

2.67

2022-09-30

1.63

2022-06-30

1.45

2022-03-31

6.48

2021-12-31

11.15

2021-09-30

11.90

2021-06-30

7.83

2021-03-31

4.57

2020-12-31

5.00

2020-09-30

20.28

2020-06-30

29.51

2020-03-31

40.65

2019-12-31

66.09

2019-09-30

33.14

2019-06-30

13.23

2019-03-31

8.39

2018-12-31

10.58

2018-09-30

2.20

2018-06-30

2.34

2018-03-31

1.41

2017-12-31

0.99

2017-09-30

0.97

2017-06-30

0.87

2017-03-31

0.77

2016-12-31

0.72

2016-09-30

0.62

2016-06-30

0.57

2016-03-31

10.87

2015-12-31

10.35

2015-09-30

12.94

2015-06-30

10.96

2015-03-31

10.56

2014-12-31

8.13

2014-09-30

10.77

2014-06-30

1.54

2014-03-31

1.59

2013-12-31

0.86

2013-09-30

0.51

2013-06-30

0.45

2013-03-31

0.54

2012-12-31

0.67

2012-09-30

0.58

2012-06-30

0.69

2012-03-31

0.87

2011-12-31

0.74

2011-09-30

0.63

2011-06-30

0.66

2011-03-31

0.70

2010-12-31

1.11

2010-09-30

0.96

2010-06-30

1.00

2010-03-31

1.22

2009-12-31

1.31

2009-09-30

1.13

2009-06-30

1.44

2009-03-31

1.28

2008-12-31

1.33

2008-09-30

1.66

2008-06-30

2.15

2008-03-31

2.30

2007-12-31

2.16

2007-09-30

1.94

2007-06-30

1.94

2007-03-31

1.26

2006-12-31

1.38

2006-09-30

0.28

2006-06-30

0.42

2006-03-31

0.44

2005-12-31

0.57

2005-09-30

0.52

2005-06-30

0.51

2005-03-31

0.61

2004-12-31

0.80

2004-09-30

1.75

2004-06-30

1.93

2004-03-31

2.18

2003-12-31

2.41

2003-09-30

2.29

2003-06-30

1.62

2003-03-31

1.67

2002-12-31

2.74

2002-09-30

1.75

Current Ratio: 31.18

LGND Current Ratio

LGND Average Current Ratio Chart

LGND Current vs Average Current Ratio Chart

LGND Current Ratio Metrics

LGND Competitors' Current Ratio

Liquidity Analysis

Current Ratio Formula & Definition

Current Ratio FAQ

LGND Current Ratio History

Related Metrics